These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Reduced muscarinic parotid secretion is underlain by impaired NO signaling in diabetic rabbits.
    Author: Roganović J, Djukić LJ, Kršljak E, Tanić N, Stojić D.
    Journal: Oral Dis; 2015 Jul; 21(5):634-40. PubMed ID: 25703905.
    Abstract:
    OBJECTIVES: The influence of experimental diabetes (alloxan, 100 mg kg(-1) ) was studied on rabbit parotid gland function. MATERIAL AND METHODS: Carbachol-induced parotid secretion in vivo, and in vitro quantification of inducible nitric oxide synthase (iNOS) mRNA expression, by real-time RT-PCR, and activity of superoxide dismutase (SOD) and total antioxidant capacity (TAC) in commercial colorimetric assays were measured in parotid glands of non-diabetic and diabetic rabbits. RESULTS: Carbachol-induced dose-dependent increase in parotid secretion significantly reduced in diabetic rabbits. Functional studies in the presence of muscarinic receptor and nitric oxide synthase (NOS) antagonists revealed that in M3 receptor-mediated carbachol secretion, nitric oxide, deriving mainly from neuronal NOS (nNOS) in control, and iNOS in diabetic rabbits, was involved. Also, upregulation of iNOS mRNA expression and enhanced SOD activity and TAC were detected in diabetic glands. CONCLUSIONS: Our data suggest that decreased M3 receptor-mediated parotid secretion in diabetic rabbits appears to be due to alterations in NO signaling, mainly due to iNOS induction, accompanied by elevated antioxidant response.
    [Abstract] [Full Text] [Related] [New Search]